ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,247Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 189

$630K Total Retail Price of All Prescriptions

Rank: 8 out of 189

439 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 9,796 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
OMEPRAZOLE 519 326 1 3
AMLODIPINE BESYLATE 462 392 2 4
LISINOPRIL 455 425 3 1
LEVOTHYROXINE SODIUM 420 327 4 5
SIMVASTATIN 412 326 5 2
PRAVASTATIN SODIUM 339 297 6 13
METOPROLOL TARTRATE 336 283 7 6
METFORMIN HCL 289 227 8 7
ATENOLOL 265 226 9 12
ATORVASTATIN CALCIUM 255 221 10 9
LOSARTAN POTASSIUM 254 198 11 20
FUROSEMIDE 251 251 12 10
CITALOPRAM HBR 222 141 13 15
HYDROCODONE-ACETAMINOPHEN 213 116 S3 14 11
FENOFIBRATE 204 154 15 36
ALENDRONATE SODIUM 201 169 16 18
TRIAMTERENE-HCTZ 194 166 17 50
GABAPENTIN 191 166 18 22
ATENOLOL-CHLORTHALIDONE 170 145 19 87
BISOPROLOL-HYDROCHLOROTHIAZIDE 163 141 20 84
ZOLPIDEM TARTRATE 159 110 21 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 109 22 23
GLYBURIDE 120 101 R 23 60
LOVASTATIN 107 91 24 21
WARFARIN SODIUM 103 102 25 14
ALLOPURINOL 101 90 26 25
TAMSULOSIN HCL 100 64 27 28
TRAMADOL HCL 99 47 28 32
RANITIDINE HCL 98 46 29 26
CYMBALTA 94 43 30 59
BENAZEPRIL HCL 92 56 31 108
SPIRIVA 89 83 32 33
MELOXICAM 88 23 33 54
ADVAIR DISKUS 85 60 34 42
IBUPROFEN 85 39 34 34
GLIMEPIRIDE 84 84 36 71
FLUTICASONE PROPIONATE 81 47 37 30
SERTRALINE HCL 81 70 37 17
CLOPIDOGREL 81 73 37 48
DIGOXIN 80 79 40 66
POLYETHYLENE GLYCOL 3350 79 0 41 64
KLOR-CON 10 78 78 42 105
AMITRIPTYLINE HCL 78 38 R 42 70
HYDROCHLOROTHIAZIDE 78 61 42 8
DOXAZOSIN MESYLATE 76 76 45 63
SYNTHROID 75 57 46 44
METFORMIN HCL ER 75 58 46 37
OXYBUTYNIN CHLORIDE 72 64 48 184
CRESTOR 71 23 49 31
FLUOXETINE HCL 68 33 50 29
POTASSIUM CHLORIDE 60 46 51 61
PREDNISONE 60 51 51 38
LIPITOR 60 48 51 57
LEVOXYL 58 37 54 110
FINASTERIDE 57 46 55 83
AZITHROMYCIN 57 42 55 47
CARVEDILOL 54 39 57 65
PLAVIX 54 50 57 74
GLYBURIDE-METFORMIN HCL 54 54 R 57 127
AMLODIPINE BESYLATE-BENAZEPRIL 54 54 57 91
METOPROLOL SUCCINATE 54 54 57 19
RAMIPRIL 50 44 62 67
ACTOS 50 25 62 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.